CHIORAZZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 19.544
AS - Asia 14.868
EU - Europa 9.752
SA - Sud America 1.761
AF - Africa 300
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 27
Totale 46.328
Nazione #
US - Stati Uniti d'America 19.015
SG - Singapore 5.113
CN - Cina 2.979
VN - Vietnam 2.967
IT - Italia 1.959
HK - Hong Kong 1.606
DE - Germania 1.567
RU - Federazione Russa 1.459
BR - Brasile 1.309
SE - Svezia 1.055
IE - Irlanda 831
GB - Regno Unito 586
UA - Ucraina 570
FR - Francia 549
IN - India 437
CA - Canada 357
KR - Corea 285
FI - Finlandia 255
ID - Indonesia 218
BD - Bangladesh 205
AT - Austria 189
AR - Argentina 167
JP - Giappone 166
TR - Turchia 161
IQ - Iraq 130
NL - Olanda 125
DK - Danimarca 121
ES - Italia 104
ZA - Sudafrica 99
MX - Messico 94
PK - Pakistan 88
PL - Polonia 85
LT - Lituania 75
SA - Arabia Saudita 68
CH - Svizzera 66
EC - Ecuador 64
PH - Filippine 63
AU - Australia 55
CO - Colombia 55
BE - Belgio 53
MY - Malesia 51
VE - Venezuela 50
IR - Iran 40
AE - Emirati Arabi Uniti 34
CL - Cile 34
EG - Egitto 33
MA - Marocco 32
PY - Paraguay 32
UZ - Uzbekistan 32
TN - Tunisia 28
ET - Etiopia 26
JO - Giordania 25
KE - Kenya 25
EU - Europa 23
TW - Taiwan 22
KZ - Kazakistan 21
NZ - Nuova Zelanda 20
OM - Oman 20
AZ - Azerbaigian 19
NP - Nepal 19
PE - Perù 19
TH - Thailandia 17
BO - Bolivia 15
CZ - Repubblica Ceca 15
UY - Uruguay 15
CR - Costa Rica 14
IL - Israele 14
DZ - Algeria 13
AL - Albania 12
HN - Honduras 11
HU - Ungheria 11
PS - Palestinian Territory 11
RO - Romania 11
JM - Giamaica 10
NG - Nigeria 10
BG - Bulgaria 9
PA - Panama 9
KG - Kirghizistan 8
NI - Nicaragua 8
SN - Senegal 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
HR - Croazia 7
AO - Angola 6
MD - Moldavia 6
RS - Serbia 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
GR - Grecia 5
KW - Kuwait 5
LB - Libano 5
LV - Lettonia 5
BN - Brunei Darussalam 4
CI - Costa d'Avorio 4
GE - Georgia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
GT - Guatemala 3
KH - Cambogia 3
MM - Myanmar 3
Totale 46.276
Città #
Singapore 3.182
Ann Arbor 2.860
Ashburn 1.599
Dallas 1.562
Hong Kong 1.527
San Jose 1.288
Ho Chi Minh City 873
Frankfurt am Main 824
Dublin 804
Woodbridge 773
Chandler 772
Milan 735
Hanoi 684
Wilmington 640
Houston 609
Fairfield 566
Dearborn 547
Jacksonville 546
New York 542
Beijing 437
Los Angeles 425
Santa Clara 399
Chicago 314
Princeton 302
Council Bluffs 262
The Dalles 257
Hefei 253
Seattle 253
Seoul 245
Nanjing 237
Boardman 192
Shanghai 177
Lauterbourg 170
Vienna 163
Cambridge 162
Buffalo 161
Jakarta 152
São Paulo 120
Moscow 111
Guangzhou 110
Orem 105
Helsinki 102
Da Nang 96
Dong Ket 92
Munich 92
Haiphong 91
Tokyo 91
Lachine 85
Lawrence 78
Toronto 77
Chennai 74
Altamura 73
Nanchang 73
Shenyang 73
Rome 69
London 65
Montreal 63
Hải Dương 62
Warsaw 59
Vilnius 58
Ha Long 57
Baghdad 56
Phoenix 54
Denver 53
Rio de Janeiro 52
Andover 51
Biên Hòa 50
Pune 50
Amsterdam 49
Carate Brianza 49
Zurich 49
Brooklyn 48
Changsha 48
Stockholm 48
Atlanta 47
Hangzhou 47
Nuremberg 47
Jinan 45
Can Tho 43
Falls Church 43
Johannesburg 43
Zhengzhou 43
Basingstoke 41
Ottawa 41
Ninh Bình 40
Quận Bình Thạnh 40
San Diego 40
Fremont 39
Brussels 38
Bắc Ninh 38
Jiaxing 38
Poplar 38
San Francisco 38
Tianjin 37
Turku 36
Columbus 35
Kunming 35
Manchester 34
Istanbul 32
Boston 31
Totale 29.156
Nome #
CIPN and its mechanism of development 596
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 575
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 500
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 490
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 483
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 445
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 441
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 425
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 422
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 417
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 417
Age-related changes in the function and structure of the peripheral sensory pathway in mice 414
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 411
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 407
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 404
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 401
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 390
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 386
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 383
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 378
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 377
Artificial apolipoprotein corona enables nanoparticle brain targeting 377
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 369
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 367
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 354
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 353
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 347
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 339
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 339
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 332
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 328
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 327
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 326
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 315
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 310
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 308
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 307
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 306
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 303
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 300
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 300
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 297
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 297
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 296
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 295
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 294
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 290
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 290
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 289
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 289
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 289
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 285
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 285
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 283
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 282
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 281
OCT2 transporter involvement in development of cisplatin toxicity 281
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 277
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 276
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 273
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 273
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 270
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 269
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 269
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 269
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 267
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 266
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 264
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 264
Multimodal experimental approach to the study of human neurological diseases 260
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 256
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 256
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 255
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 254
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 253
MSCs effect on Dark Agouti rats affected by chronic EAE 252
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 250
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 249
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 248
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 246
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 246
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 245
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 245
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 244
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 244
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 244
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 244
Genetic factors influencing the development of vincristine-induced neurotoxicity 244
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 243
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 243
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 241
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 241
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 239
Current view in platinum drug mechanisms of peripheral neurotoxicity 239
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 239
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 238
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 238
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 238
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 237
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 236
Totale 31.236
Categoria #
all - tutte 141.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021570 0 0 0 0 0 0 0 0 0 0 204 366
2021/20221.946 152 234 171 177 139 181 95 106 82 143 134 332
2022/20233.484 389 846 380 332 259 540 63 181 277 51 104 62
2023/20242.986 97 98 101 146 386 725 508 163 158 68 68 468
2024/20257.921 452 898 712 367 624 294 512 284 899 1.038 674 1.167
2025/202619.979 2.966 1.867 2.450 1.776 1.957 1.278 2.871 1.075 1.722 1.755 262 0
Totale 47.820